Zobrazeno 1 - 10
of 1 133
pro vyhledávání: '"Pearce RE"'
Autor:
Parvez MM; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Thakur A; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Mehrotra A; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA., Stancil S; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Pearce RE; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Basit A; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA., Leeder JS; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy-Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Prasad B; Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Oct; Vol. 116 (4), pp. 1090-1099. Date of Electronic Publication: 2024 Jul 02.
Autor:
Kyler KE; Division of Hospital Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Gaedigk A; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA., Abdel-Rahman S; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Staggs VS; IDDI, Inc. (Formerly Biostatistics & Epidemiology Core, Children's Mercy Research Institute, Kansas City, Missouri), Raleigh, North Carolina, USA., Pearce RE; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA., Toren P; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA., Leeder JS; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA., Shakhnovich V; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, Missouri, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13782.
Autor:
Stancil SL; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri slstancil@cmh.edu., Pearce RE; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri., Staggs VS; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri., Leeder JS; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2023 Dec; Vol. 51 (12), pp. 1578-1582. Date of Electronic Publication: 2023 Sep 21.
Autor:
Leeder JS; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Wright KJ; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA., Staggs VS; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Biostatistics & Epidemiology Core, Division of Health Services and Outcomes Research, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.; Division of Developmental and Behavioral Sciences, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA., Soden SE; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Lin YS; Department of Pharmaceutics, University of Washington, Seattle, Washington, USA., Pearce RE; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri, USA.; School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Oct; Vol. 15 (10), pp. 2514-2527. Date of Electronic Publication: 2022 Aug 23.
Autor:
Feldman K; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Kearns GL; Texas Christian University and UNTHSC School of Medicine, Fort Worth, Texas, USA., Pearce RE; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Abdel-Rahman SM; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Steven Leeder J; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Friesen A; Oklahoma School of Community Medicine, Tulsa, Oklahoma, USA., Staggs VS; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Gaedigk A; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA., Weigel J; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Shakhnovich V; University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.; Children's Mercy Kansas City, Kansas City, Missouri, USA.; Center for Children's Healthy Lifestyles & Nutrition, Kansas City, Missouri, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 May; Vol. 15 (5), pp. 1155-1166. Date of Electronic Publication: 2022 Feb 14.
Autor:
Dinh JC; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA., Boone EC; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA., Staggs VS; Biostatistics and Epidemiology Core, Health Services and Outcomes Research, Children's Mercy Kansas City, Kansas City, Missouri, USA.; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Pearce RE; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA., Wang WY; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA., Gaedigk R; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA., Leeder JS; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Gaedigk A; Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Mar; Vol. 111 (3), pp. 646-654. Date of Electronic Publication: 2021 Nov 30.
Autor:
Stancil SL; Division of Adolescent Medicine (S.L.S.), Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (S.L.S., W.N., R.E.P., J.S.L.), and Biostatistics and Epidemiology Core (V.S.S.) Children's Mercy Kansas City, Kansas City, Missouri; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (S.L.S., W.N., R.E.P., V.S.S., J.S.L.) slstancil@cmh.edu., Nolte W; Division of Adolescent Medicine (S.L.S.), Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (S.L.S., W.N., R.E.P., J.S.L.), and Biostatistics and Epidemiology Core (V.S.S.) Children's Mercy Kansas City, Kansas City, Missouri; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (S.L.S., W.N., R.E.P., V.S.S., J.S.L.)., Pearce RE; Division of Adolescent Medicine (S.L.S.), Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (S.L.S., W.N., R.E.P., J.S.L.), and Biostatistics and Epidemiology Core (V.S.S.) Children's Mercy Kansas City, Kansas City, Missouri; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (S.L.S., W.N., R.E.P., V.S.S., J.S.L.)., Staggs VS; Division of Adolescent Medicine (S.L.S.), Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (S.L.S., W.N., R.E.P., J.S.L.), and Biostatistics and Epidemiology Core (V.S.S.) Children's Mercy Kansas City, Kansas City, Missouri; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (S.L.S., W.N., R.E.P., V.S.S., J.S.L.)., Leeder JS; Division of Adolescent Medicine (S.L.S.), Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation (S.L.S., W.N., R.E.P., J.S.L.), and Biostatistics and Epidemiology Core (V.S.S.) Children's Mercy Kansas City, Kansas City, Missouri; Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri (S.L.S., W.N., R.E.P., V.S.S., J.S.L.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2022 Feb; Vol. 50 (2), pp. 168-173. Date of Electronic Publication: 2021 Nov 02.
Autor:
Leeder JS; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.) sleeder@cmh.edu., Dinh JC; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.)., Gaedigk A; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.)., Staggs VS; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.)., Prasad B; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.)., Pearce RE; Certara, Princeton, NJ (J.C.D.); Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics and Children's Mercy Research Institute, Children's Mercy Kansas City, Kansas City, Missouri (J.S.L., J.C.D., A.G., V.S.S., R.E.P.); Department of Pharmaceutical Sciences, Washington State University, Spokane, Washington (B.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2022 Jan; Vol. 50 (1), pp. 24-32. Date of Electronic Publication: 2021 Oct 22.
Autor:
Mir F; Section of Pediatric Infectious Disease, Pediatrics and Child Health, the Aga Khan University, Karachi, Pakistan fatima.mir@aku.edu., Pearce RE; Pediatric Clinical Pharmacology, The Childrens Mercy Hospital (CMH), University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Baig-Ansari N; Indus Hospital Research Center (IHRC), The Indus Hospital, Karachi, Pakistan., Qazi S; Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva, Switzerland., Barrett JS; Quantitative Sciences, Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA., Abdel-Rahman S; Pediatric Clinical Pharmacology, The Childrens Mercy Hospital (CMH), University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA., Kearns G; Department of Medical Research, Children's Mercy Hospital, Kansas City, Missouri, USA.; Pediatrics, TCU-UNTHSC School of Medicine, Fort Worth, Texas, USA., Zaidi AK; Section of Pediatric Infectious Disease, Pediatrics and Child Health, the Aga Khan University, Karachi, Pakistan.
Publikováno v:
Archives of disease in childhood [Arch Dis Child] 2020 Dec; Vol. 105 (12), pp. 1208-1214. Date of Electronic Publication: 2020 May 13.
Autor:
Skaar, Todd C.1 (AUTHOR) tskaar@iu.edu, Myers, Rachel A.2 (AUTHOR), Fillingim, Roger B.3 (AUTHOR), Callaghan, John T.1 (AUTHOR), Cicali, Emily4 (AUTHOR), Eadon, Michael T.1,5 (AUTHOR), Elwood, Erica N.4 (AUTHOR), Ginsburg, Geoffrey S.6 (AUTHOR), Lynch, Sheryl1 (AUTHOR), Nguyen, Khoa A.4 (AUTHOR), Obeng, Aniwaa Owusu7,8,9 (AUTHOR), Park, Haesuk10,11 (AUTHOR), Pratt, Victoria M.12 (AUTHOR), Rosenman, Marc13,14 (AUTHOR), Sadeghpour, Azita15 (AUTHOR), Shuman, Saskia16 (AUTHOR), Singh, Rajbir17 (AUTHOR), Tillman, Emma M.1 (AUTHOR), Volpi, Simona18 (AUTHOR), Wiisanen, Kristin4 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Aug2024, Vol. 17 Issue 8, p1-14. 14p.